Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0090
-0.0010 (-10.00%)
Dec 18, 2025, 2:31 PM EST
Regen BioPharma Market Cap
Regen BioPharma has a market cap or net worth of $1.08 million as of December 18, 2025. Its market cap has decreased by -33.16% in one year.
Market Cap
1.08M
Enterprise Value
2.12M
Revenue
236.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since September 4, 2014, Regen BioPharma's market cap has decreased from 19.72M to 1.08M, a decrease of -94.52%. That is a compound annual growth rate of -22.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 1.08M | -28.69% |
| Dec 31, 2024 | 1.52M | -57.47% |
| Dec 29, 2023 | 3.56M | -81.90% |
| Dec 30, 2022 | 19.69M | -70.55% |
| Dec 31, 2021 | 66.86M | 9,040.40% |
| Dec 31, 2020 | 731.51K | 400.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 291.10M |